Skip to main content

Alison H. Peters


[email protected]



Alison has a broad health law practice that encompasses counseling clients on regulatory, compliance, transactional, and legislative matters. She works with clients across the health care and life sciences sectors, including pharmaceutical and medical device manufacturers, physician practice groups, hospital systems, clinical laboratories, pharmacy benefit managers (PBMs), private equity firms, trade groups, and executives of health care entities.

Alison has extensive experience with matters involving fraud and abuse allegations, the False Claims Act, the Physician Self-Referral Law (Stark) law and related rules, the Anti-Kickback Statute, and the Beneficiary Inducements Statute. Along with representing clients in investigations and proceedings by government entities, including the Center for Medicare & Medicaid Services, and the US Department of Health and Human Services Office of Inspector General, she advocates before Congressional committees on behalf of pharmaceutical and biotechnology clients. Alison also advises clients on FDA marketing practices, HIPAA compliance, federal and state drug pricing requirements, compensation and investment arrangements, licensing, reimbursement, corporate practice of medicine rules, and transaction structures. Clients also seek her guidance on regulatory-based diligence reviews and compliance investigations.

Prior to joining Mintz, Alison was an associate at a multinational law firm, where she handled a wide range of health care regulatory and transactional matters.

While earning her JD, Alison served as an executive online editor of the Georgetown Journal of International Law and clerked in a plaintiffs’-side False Claims Act practice. She also studied at Keio University in Tokyo, Japan, where she focused on international business transactional law.

Before law school, Alison led advertising strategy for Fortune 500 consumer and health care brands.


  • American Bar Association, Health Law Section
  • Health Law Committee, District of Columbia Bar Association (Oct. 2023 – present)
  • New York Bar (2019 – present)
  • District of Columbia Bar Association (2020 – present)
Read less